Challenges in Second-Line Therapy for Advanced Pancreatic Cancer: The Search for Predictive Markers
Patients with advanced pancreatic cancer face poor outcomes. After first-line therapy failure, only ~50% receive second-line treatment. Choosing this therapy is challenging due to the lack of reliable predictive markers for its effectiveness